Teva Pharmaceutical Industries Limited
TEVA
Ранг среди акций
#13240
Teva Pharmaceutical Industries Limited operates as a prominent global... Teva Pharmaceutical Industries Limited operates as a prominent global pharmaceutical firm, involved in the research, development, manufacturing, marketing, and distribution of generic, specialized, and biopharmaceutical products throughout North America, Europe, and other international regions. The company's diverse portfolio encompasses sterile preparations, hormonal therapies, high-potency drugs, and cytotoxic substances, supplied in a wide array of dosage forms such as tablets, capsules, injectable solutions, inhalants, oral liquids, transdermal patches, topical ointments, and creams. Furthermore, Teva develops, produces, and sells active pharmaceutical ingredients (APIs). A significant portion of its research and product development is concentrated on the central nervous system, pain management, respiratory illnesses, and oncology. Leading products for the central nervous system include Copaxone, utilized for relapsing multiple sclerosis; AJOVY, an option for migraine prevention; and AUSTEDO, prescribed for tardive dyskinesia and chorea linked to Huntington's disease. Within the respiratory domain, addressing asthma and chronic obstructive pulmonary disease, Teva offers products like ProAir, QVAR, various Digihaler and RespiClick formulations, along with BRALTUS and CINQAIR/CINQAERO. Their oncology division features treatments such as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. The company also collaborates with MedinCell on the creation and commercialization of multiple extended-release injectable products, including a risperidone suspension designed for individuals with schizophrenia. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
Цена акции
$41.51
Последняя синхронизация: 2026-10-16
Рыночная капитализация
$483.77M
Изменение (1 день)
-0.85%
Изменение (1 год)
107.47%
Страна
IL
Торговля Teva Pharmaceutical Industries Limited (TEVA)
Категория
Healthcare
Рыночная капитализация Teva Pharmaceutical Industries Limited(TEVA)
Рыночная капитализация: $483.77M
По состоянию на October 2026 рыночная капитализация Teva Pharmaceutical Industries Limited составляет $483.77M. Согласно нашим данным, Teva Pharmaceutical Industries Limited занимает 13240th место среди самых ценных компаний мира по рыночной капитализации. Рыночная капитализация — это общая рыночная стоимость всех находящихся в обращении акций публичной компании и обычно используется для оценки ее стоимости.
История рыночной капитализации Teva Pharmaceutical Industries Limited с 2010 по 2026
TEVA по сравнению с пятеркой самых популярных stocks
